Work

Shortened therapy of eight weeks with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infection

Year: 2018

Type: article

Study design: Clinical Trial

Source: Journal of Viral Hepatitis

DOI: 10.1111/jvh.12917

Authors: M. Martinello, S. Bhagani, E. Gane, C. Orkin, G. Cooke, G. J. Dore, K. Petoumenos, T. L. Applegate, E. Tu, P. Marks, N. Pagani, J. Grebely, M. Nelson, G. V. Matthews

Institutions: UNSW Sydney, St Vincent's Hospital Sydney, Kirby Institute, The Royal Free Hospital, Auckland City Hospital, Barts Health NHS Trust, Royal London Hospital, St Mary's Hospital, Chelsea and Westminster Hospital

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Bristol-Myers Squibb, Infectious Diseases Society of America, AbbVie, Department of Health and Ageing, Australian Government, National Health and Medical Research Council

OpenAlex ID: W2802140772

FWCI: 2.267

Cites: 22

Cited by: 28

Related to: 10